Netramark Holdings Inc. — Capital/Financing Update 2021

May 21, 2021

==> picture [212 x 51] intentionally omitted <==

May 21, 2021

VIA SEDAR

British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan Ontario Securities Commission Office of the Yukon Superintendent of Securities

Dear Sirs/Mesdames:

Re: Nurosene Health Inc. (the "Corporation") – Final Prospectus dated May 20, 2021

We refer to the final prospectus of the Corporation dated May 20, 2021 (the " Prospectus ") relating to the distribution of a minimum of 5,555,555 units and a maximum of 8,888,888 common shares of the Corporation (the " Common Shares ") at a price of $0.90 per Common Share.

We consent to the use of our firm name on page iv and under the heading "Experts" in the Prospectus.

We confirm that we have read the Prospectus and have no reason to believe that there are any misrepresentations in the information contained therein that are within our knowledge as a result of the services performed by us in connection with the preparation of the Prospectus.

Yours truly,

BURSTALL LLP

(signed) "Burstall LLP"

==> picture [382 x 42] intentionally omitted <==